Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SCAI promotes error-free repair of DNA interstrand crosslinks via the Fanconi anemia pathway. | EMBO Rep | 2022 | 35156773 | PubTator, text mining | PubMed |
| Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma. | Neuro Oncol | 2022 | 35148403 | PubTator, text mining | PubMed |
| Characterization of the nucleotide excision repair pathway and evaluation of compounds for overcoming the cisplatin resistance of non‑small cell lung cancer cell lines. | Oncol Rep | 2022 | 35147203 | PubTator, text mining | PubMed |
| Genome-wide association study of serum tumor markers in Southern Chinese Han population. | BMC Cancer | 2022 | 35144566 | PubTator, text mining | PubMed |
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| Bioinformatics analysis deciphering the transcriptomic signatures associated with signalling pathways and prognosis in the myelodysplastic syndromes. | Hematology | 2022 | 35134316 | PubTator, text mining | PubMed |
| Mechanism of action of nucleotide excision repair machinery. | Biochem Soc Trans | 2022 | 35076656 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| XRCC4 and MRE11 Roles and Transcriptional Response to Repair of TALEN-Induced Double-Strand DNA Breaks. | Int J Mol Sci | 2022 | 35054780 | PubTator, text mining | PubMed |
| CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival. | Cancers (Basel) | 2022 | 35053516 | PubTator, text mining | PubMed |
| Osteogenesis Imperfecta: Search for Mutations in Patients from the Republic of Bashkortostan (Russia). | Genes (Basel) | 2022 | 35052464 | PubTator, text mining | PubMed |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. | Cancer Treat Rev | 2022 | 35051883 | PubTator, text mining | PubMed |
| Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2. | Proc Natl Acad Sci U S A | 2022 | 35042798 | PubTator, text mining | PubMed |
| Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. | Nucleic Acids Res | 2022 | 35037045 | PubTator, text mining | PubMed |
| A combination of direct reversion and nucleotide excision repair counters the mutagenic effects of DNA carboxymethylation. | DNA Repair (Amst) | 2022 | 35030424 | PubTator, text mining | PubMed |
| The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. | Int J Mol Sci | 2022 | 35008915 | PubTator, text mining | PubMed |
| Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation. | Radiother Oncol | 2022 | 34990726 | PubTator, text mining | PubMed |
| Gerontology through the Eyes of 21st Century Toxicology. | Chem Res Toxicol | 2022 | 34985863 | PubTator, text mining | PubMed |
| Engineering Supramolecular Nanomedicine for Targeted Near Infrared-triggered Mitochondrial Dysfunction to Potentiate Cisplatin for Efficient Chemophototherapy. | ACS Nano | 2022 | 34962119 | PubTator, text mining | PubMed |
| Deciphering the Core Metabolites of Fanconi Anemia by Using a Multi-Omics Composite Network. | J Microbiol Biotechnol | 2022 | 34954697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=35